The emerging role of proteases in retinal ganglion cell death

Experimental Eye Research

Volumn 82, Issue 1, 2006, Pages 5-12

  Chintala, Shravan K ^a  

^a OAKLAND UNIVERSITY   (United States)

Author keywords

And glaucoma; Matrix metalloproteinases; Plasminogen activators; Proteases; Retina; Retinal degeneration; Retinal ganglion cells

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; GLUTAMATE RECEPTOR; INTERSTITIAL COLLAGENASE; KAINIC ACID; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 17; NEUTROPHIL COLLAGENASE; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; PLASMINOGEN ACTIVATOR INHIBITOR 3; PROTEINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE RECEPTOR;

CALCIUM TRANSPORT; CELL DEATH; CELL LOSS; DRUG MECHANISM; ENZYME REGULATION; EXTRACELLULAR MATRIX; GLAUCOMA; HUMAN; NONHUMAN; PRIORITY JOURNAL; RETINA GANGLION CELL; RETINA INJURY; REVIEW; VISUAL IMPAIRMENT;

ANIMALS; CALCIUM; CELL DEATH; EXTRACELLULAR MATRIX; GLAUCOMA, OPEN-ANGLE; HUMANS; MATRIX METALLOPROTEINASES; MICE; MICE, KNOCKOUT; NEUROGLIA; PEPTIDE HYDROLASES; PLASMINOGEN ACTIVATORS; RETINAL GANGLION CELLS; SIGNAL TRANSDUCTION;

EID: 30344460345     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2005.07.013     Document Type: Review

References (96)

1. O.A. Agapova, C.S. Ricard, M. Salvador-Silva, and M.R. Hernandez Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes Glia 33 2001 205 216
2. O.A. Agapova, P.L. Kaufman, M.J. Lucarelli, B.T. Gabelt, and M.R. Hernandez Differential expression of matrix metalloproteinases in monkey eyes with experimental glaucoma or optic nerve transection Brain Res. 967 2003 132 143
3. E. Angles-Cano Overview on fibrinolysis: plasminogen activation pathways on fibrin and cell surfaces Chem. Phys. Lipids 67-68 1994 353 362
4. A.J. Bellezza, C.J. Rintalan, H.W. Thompson, J.C. Downs, R.T. Hart, and C.F. Burgoyne Deformation of the lamina cribrosa and anterior scleral canal wall in early experimental glaucoma Invest. Ophthalmol. Vis. Sci. 44 2003 623 637
5. H. Birkedal-Hansen, W.G. Moore, M.K. Bodden, L.J. Windsor, B. Birkedal-Hansen, A. DeCarlo, and J.A. Engler Matrix metalloproteinases: a review Crit. Rev. Oral Biol. Med. 4 1993 197 250
6. J. Bizik, A. Lizonova, R.W. Stephens, M. Grofova, and A. Vaheri Plasminogen activation by t-PA on the surface of human melanoma cells in the presence of alpha 2-macroglobulin secretion Cell Regul. 1 1990 895 905
7. F. Blasi Molecular mechanisms of protease-mediated tumor invasiveness J. Surg. Oncol. Suppl. 3 1993 21 23
8. F. Blasi, N. Behrendt, M.V. Cubellis, V. Ellis, L.R. Lund, M.T. Masucci, L.B. Moller, D.P. Olson, N. Pedersen, and M. Ploug The urokinase receptor and regulation of cell surface plasminogen activation Cell Differ. Dev. 32 1990 247 253
9. J.H. Brandstatter, E. Hartveit, M. Sassoe-Pognetto, and H. Wassle Expression of NMDA and high-affinity kainate receptor subunit mRNAs in the adult rat retina Eur. J. Neurosci. 6 1994 1100 1112
10. C.E. Brinckerhoff, and L.M. Matrisian Matrix metalloproteinases: a tail of a frog that became a prince Nat. Rev. Mol. Cell Biol. 3 2002 207 214
11. D.E. Brooks, G.A. Garcia, E.B. Dreyer, D. Zurakowski, and R.E. Franco-Bourland Vitreous body glutamate concentration in dogs with glaucoma Am. J. Vet. Res. 58 1997 864 867
12. G. Bu, I. Warshawsky, and A.L. Schwartz Cellular receptors for the plasminogen activators Blood 83 1994 3427 3436
13. L. Carter-Dawson, M.L. Crawford, R.S. Harwerth, E.L. Smith III, R. Feldman, F.F. Shen, C.K. Mitchell, and A. Whitetree Vitreal glutamate concentration in monkeys with experimental glaucoma Invest. Ophthalmol. Vis. Sci. 43 2002 2633 2637
14. T. Chavakis, S.M. Kanse, A.E. May, and K.T. Preissner Haemostatic factors occupy new territory: the role of the urokinase receptor system and kininogen in inflammation Biochem. Soc. Trans. 30 2002 168 173
15. Z.L. Chen, and S. Strickland Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin Cell 91 1997 917 925
16. S.K. Chintala, J.C. Tonn, and J.S. Rao Matrix metalloproteinases and their biological function in human gliomas Int. J. Dev. Neurosci. 17 1999 495 502
17. S.K. Chintala, X. Zhang, J.S. Austin, and M.E. Fini Deficiency in matrix metalloproteinase gelatinase B (MMP-9) protects against retinal ganglion cell death after optic nerve ligation J. Biol. Chem. 277 2002 47461 47468
18. S.P. Christow, R. Bychkov, C. Schroeder, R. Dietz, H. Haller, I. Dumler, and D.C. Gulba Urokinase activates calcium-dependent potassium channels in U937 cells via calcium release from intracellular stores Eur. J. Biochem. 265 1999 264 272
19. K. Dano, P.A. Andreasen, J. Grondahl-Hansen, P. Kristensen, L.S. Nielsen, and L. Skriver Plasminogen activators, tissue degradation, and cancer Adv. Cancer Res. 44 1985 139 266
20. E.B. Dreyer, D. Zurakowski, R.A. Schumer, S.M. Podos, and S.A. Lipton Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma Arch. Ophthalmol. 114 1996 299 305
21. D. Ehrlich, and I.G. Morgan Kainic acid destroys displaced amacrine cells in post-hatch chicken retina Neurosci. Lett. 17 1980 43 48
22. R.D. Fechtner, and R.N. Weinreb Mechanisms of optic nerve damage in primary open angle glaucoma Surv. Ophthalmol. 39 1994 23 42
23. M. Fernandez-Monreal, J.P. Lopez-Atalaya, K. Benchenane, F. Leveille, M. Cacquevel, L. Plawinski, E.T. MacKenzie, G. Bu, A. Buisson, and D. Vivien Is tissue-type plasminogen activator a neuromodulator? Mol. Cell. Neurosci. 25 2004 594 601
24. E.L. Fletcher Alterations in neurochemistry during retinal degeneration Microsc. Res. Tech. 50 2000 89 102
25. E.L. Fletcher, and M. Kalloniatis Localisation of amino acid neurotransmitters during postnatal development of the rat retina J. Comp. Neurol. 380 1997 449 471
26. L. Guo, S.E. Moss, R.A. Alexander, R.R. Ali, F.W. Fitzke, and M.F. Cordeiro Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix Invest. Ophthalmol. Vis. Sci. 46 2005 175 182
27. I.O. Haefliger, J.C. Fleischhauer, and J. Flammer In glaucoma, should enthusiasm about neuroprotection be tempered by the experience obtained in other neurodegenerative disorders? Eye 14 2000 464 472
28. W. Halfter, M. Willem, and U. Mayer Basement membrane-dependent survival of retinal ganglion cells Invest. Ophthalmol. Vis. Sci. 46 2005 1000 1009
29. M. Honjo, H. Tanihara, N. Kido, M. Inatani, K. Okazaki, and Y. Honda Expression of ciliary neurotrophic factor activated by retinal Muller cells in eyes with NMDA- and kainic acid-induced neuronal death Invest. Ophthalmol. Vis. Sci. 41 2000 552 560
30. Y. Izumi, A.M. Benz, C.O. Kurby, J. Labruyere, C.F. Zorumski, M.T. Price, and J.W. Olney An ex vivo rat retinal preparation for excitotoxicity studies J. Neurosci. Methods 60 1995 219 225
31. Y. Izumi, C.O. Kirby-Sharkey, A.M. Benz, J. Labruyere, M.T. Price, D.F. Wozniak, C.F. Zorumski, and J.W. Olney Age dependent sensitivity of the rat retina to the excitotoxic action of N-methyl-d-aspartate Neurobiol. Dis. 2 1995 139 144
32. E.C. Johnson, J.C. Morrison, S. Farrell, L. Deppmeier, C.G. Moore, and M.R. McGinty The effect of chronically elevated intraocular pressure on the rat optic nerve head extracellular matrix Exp. Eye Res. 62 1996 663 674
33. J. Jourquin, E. Tremblay, N. Decanis, G. Charton, S. Hanessian, A.M. Chollet, T. Le Diguardher, M. Khrestchatisky, and S. Rivera Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate Eur. J. Neurosci. 18 2003 1507 1517
34. K.K. Kane Fibrinolysis - a review Ann. Clin. Lab. Sci. 14 1984 443 449
35. T.W. Kim, K.B. Kang, H.K. Choung, K.H. Park, and D.M. Kim Elevated glutamate levels in the vitreous body of an in vivo model of optic nerve ischemia Arch. Ophthalmol. 118 2000 533 536
36. K.Y. Kim, W.K. Ju, and A.H. Neufeld Neuronal susceptibility to damage: comparison of the retinas of young, old and old/caloric restricted rats before and after transient ischemia Neurobiol. Aging 25 2004 491 500
37. M. Kumada, M. Niwa, A. Hara, H. Matsuno, H. Mori, S. Ueshima, O. Matsuo, T. Yamamoto, and O. Kozawa Tissue type plasminogen activator facilitates NMDA-receptor-mediated retinal apoptosis through an independent fibrinolytic cascade Invest. Ophthalmol. Vis. Sci. 46 2005 1504 1507
38. Kumada, M., Niwa, M., Wan, X., Matsuno, H., Hara, A., Mori, H., Matsuo, O., Yamamoto, T., Kozawa, O., in Press. Endogenous tissue plasminogen activator facilitiates NMDA-induced retinal damage. Toxicol. Appl. Pharmocol., Available online at www.sciencedirect.com.
39. T.T. Lam, A.S. Abler, J.M. Kwong, and M.O. Tso N-methyl-d-aspartate (NMDA) - induced apoptosis in rat retina Invest. Ophthalmol. Vis. Sci. 40 1999 2391 2397
40. H. Levkovitch-Verbin, K.R. Martin, H.A. Quigley, L.A. Baumrind, M.E. Pease, and D. Valenta Measurement of amino acid levels in the vitreous humor of rats after chronic intraocular pressure elevation or optic nerve transection J. Glaucoma 11 2002 396 405
41. Y. Li, C.L. Schlamp, and R.W. Nickells Experimental induction of retinal ganglion cell death in adult mice Invest. Ophthalmol. Vis. Sci. 40 1999 1004 1008
42. H.R. Lijnen Elements of the fibrinolytic system Ann. NY Acad. Sci. 936 2001 226 236
43. P. Lipton Ischemic cell death in brain neurons Physiol. Rev. 79 1999 1431 1568
44. S.A. Lipton Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage Surv. Ophthalmol. 48 2003 S38 S46
45. S.A. Lipton, and P.A. Rosenberg Excitatory amino acids as a final common pathway for neurologic disorders N. Engl. J. Med. 330 1994 613 622
46. D.R. Lucas, and J.P. Newhouse The toxic effects os sodium L-glutamate on the inner layers of the retina Arch. Ophthalmol. 58 1957 193 201
47. Mali, S., Cheng, M., Chintala, S.K., in Press. Plasminogen activators promote excitotoxicity-induced retinal damage. Faseb J.
48. S. Manabe, and S.A. Lipton Divergent NMDA signals leading to proapoptotic and antiapoptotic pathways in the rat retina Invest. Ophthalmol. Vis. Sci. 44 2003 385 392
49. L.M. Matrisian, J. Wright, K. Newell, and J.P. Witty Matrix-degrading metalloproteinases in tumor progression Princess Takamatsu Symp. 24 1994 152 161
50. I.G. Morgan AMPA is a powerful neurotoxin in the chicken retina Neurosci. Lett. 79 1987 267 271
51. I.G. Morgan, and C.A. Ingham Kainic acid affects both plexiform layers of chicken retina Neurosci. Lett. 21 1981 275 280
52. H. Nagase, K. Suzuki, Y. Itoh, C.C. Kan, M.R. Gehring, W. Huang, and K. Brew Involvement of tissue inhibitors of metalloproteinases (TIMPS) during matrix metalloproteinase activation Adv. Exp. Med. Biol. 389 1996 23 31
53. O. Nicole, F. Docagne, C. Ali, I. Margaill, P. Carmeliet, E.T. MacKenzie, D. Vivien, and A. Buisson The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling Nat. Med. 7 2001 59 64
54. Y. Nishizawa Glutamate release and neuronal damage in ischemia Life Sci. 69 2001 369 381
55. J.D. Pena, O. Agapova, B.T. Gabelt, L.A. Levin, M.J. Lucarelli, P.L. Kaufman, and M.R. Hernandez Increased elastin expression in astrocytes of the lamina cribrosa in response to elevated intraocular pressure Invest. Ophthalmol. Vis. Sci. 42 2001 2303 2314
56. H.A. Quigley Number of people with glaucoma worldwide Br. J. Ophthalmol. 80 1996 389 393
57. H.A. Quigley, R.W. Nickells, L.A. Kerrigan, M.E. Pease, D.J. Thibault, and D.J. Zack Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis Invest. Ophthalmol. Vis. Sci. 36 1995 774 786
58. A.D. Rogove, C. Siao, B. Keyt, S. Strickland, and S.E. Tsirka Activation of microglia reveals a non-proteolytic cytokine function for tissue plasminogen activator in the central nervous system J. Cell Sci. 112 1999 4007 4016
59. A.D. Rogove, W. Lu, and S.E. Tsirka Microglial activation and recruitment, but not proliferation, suffice to mediate neurodegeneration Cell Death Differ. 9 2002 801 806
60. A.M. Romanic, R.F. White, A.J. Arleth, E.H. Ohlstein, and F.C. Barone Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size Stroke 29 1998 1020 1030
61. G.A. Rosenberg, J.E. Dencoff, P.G. McGuire, L.A. Liotta, and W.G. Stetler-Stevenson Injury-induced 92-kilodalton gelatinase and urokinase expression in rat brain Lab. Invest. 71 1994 417 422
62. R. Schwarcz, and J.T. Coyle Kainic acid: neurotoxic effects after intraocular injection Invest. Ophthalmol. Vis. Sci. 16 1977 141 148
63. R. Siliprandi, R. Canella, G. Carmignoto, N. Schiavo, A. Zanellato, R. Zanoni, and G. Vantini N-methyl-D-aspartate-induced neurotoxicity in the adult rat retina Vis. Neurosci. 8 1992 567 573
64. D.R. Sisk, and T. Kuwabara Histologic changes in the inner retina of albino rats following intravitreal injection of monosodium L-glutamate Graefes Arch. Clin. Exp. Ophthalmol. 223 1985 250 258
65. D.R. Sisk, T. Kuwabara, and A.D. Kirsch Behavioral recovery in albino rats with glutamate-damaged retinas Invest. Ophthalmol. Vis. Sci. 25 1984 1124 1128
66. R.G. Sitrin, R.F. Todd 3rd, E. Albrecht, and M.R. Gyetko The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes J. Clin. Invest. 97 1996 1942 1951
67. J.M. Sivak, and M.E. Fini MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology Prog. Retin. Eye Res. 21 2002 1 14
68. E. Stefansson, C.A. Wilson, T. Schoen, and T. Kuwabara Experimental ischemia induces cell mitosis in the adult rat retina Invest. Ophthalmol. Vis. Sci. 29 1988 1050 1055
69. H.K. Tan, D. Heywood, G.S. Ralph, A. Bienemann, A.H. Baker, and J.B. Uney Tissue inhibitor of metalloproteinase 1 inhibits excitotoxic cell death in neurons Mol. Cell. Neurosci. 22 2003 98 106
70. S. Thanos The relationship of microglial cells to dying neurons during natural neuronal cell death and axotomy-induced degeneration of the rat retina Eur. J. Neurosci. 3 1991 1189 1207
71. S. Thanos, and R. Naskar Correlation between retinal ganglion cell death and chronically developing inherited glaucoma in a new rat mutant Exp. Eye Res. 79 2004 119 129
72. S. Thanos, J. Mey, and M. Wild Treatment of the adult retina with microglia-suppressing factors retards axotomy-induced neuronal degradation and enhances axonal regeneration in vivo and in vitro J. Neurosci. 13 1993 455 466
73. S.E. Tsirka, A. Gualandris, D.G. Amaral, and S. Strickland Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator Nature 377 1995 340 344
74. S.E. Tsirka, A.D. Rogove, and S. Strickland Neuronal cell death and tPA Nature 384 1996 123 124
75. S.E. Tsirka, A.D. Rogove, T.H. Bugge, J.L. Degen, and S. Strickland An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus J. Neurosci. 17 1997 543 552
76. E.M. Ullian, W.B. Barkis, S. Chen, J.S. Diamond, and B.A. Barres Invulnerability of retinal ganglion cells to NMDA excitotoxicity Mol. Cell. Neurosci. 26 2004 544 557
77. J.D. Vassalli, A.P. Sappino, and D. Belin The plasminogen activator/plasmin system J. Clin. Invest. 88 1991 1067 1072
78. C.K. Vorwerk, M.S. Gorla, and E.B. Dreyer An experimental basis for implicating excitotoxicity in glaucomatous optic neuropathy Surv. Ophthalmol. 43 1999 S142 S150
79. C.K. Vorwerk, D. Zurakowski, L.M. McDermott, C. Mawrin, and E.B. Dreyer Effects of axonal injury on ganglion cell survival and glutamate homeostasis Brain Res. Bull. 62 2004 485 490
80. T.H. Vu, and Z. Werb Matrix metalloproteinases: effectors of development and normal physiology Genes Dev. 14 2000 2123 2133
81. T.H. Vu, J.M. Shipley, G. Bergers, J.E. Berger, J.A. Helms, D. Hanahan, S.D. Shapiro, R.M. Senior, and Z. Werb MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes Cell 93 1998 411 422
82. S. Wamsley, B.T. Gabelt, D.B. Dahl, G.L. Case, R.W. Sherwood, C.A. May, M.R. Hernandez, and P.L. Kaufman Vitreous glutamate concentration and axon loss in monkeys with experimental glaucoma Arch. Ophthalmol. 123 2005 64 70
83. X. Wang, S.S. Tay, and Y.K. Ng An immunohistochemical study of neuronal and glial cell reactions in retinae of rats with experimental glaucoma Exp. Brain Res. 132 2000 476 484
84. X. Wang, S.R. Lee, K. Arai, K. Tsuji, G.W. Rebeck, and E.H. Lo Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator Nat. Med. 9 2003 1313 1317
85. J.F. Woessner W.C. Parks R.P. Mecham Matrix Metalloproteinases 1998 Academic Press San Diego 1 14
86. J.F. Woessner Jr. Matrix metalloproteinase inhibition. From the Jurassic to the third millennium Ann. N Y Acad. Sci. 878 1999 388 403
87. J.F. Woessner Jr. MMPs and TIMPs - an historical perspective Mol. Biotechnol. 22 2002 33 49
88. E. Yoles, and M. Schwartz Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerve Arch. Ophthalmol. 116 1998 906 910
89. V.W. Yong, C.A. Krekoski, P.A. Forsyth, R. Bell, and D.R. Edwards Matrix metalloproteinases and diseases of the CNS Trends Neurosci. 21 1998 75 80
90. V.W. Yong, C. Power, P. Forsyth, and D.R. Edwards Metalloproteinases in biology and pathology of the nervous system Nat. Rev. Neurosci. 2 2001 502 511
91. G.D. Zeevalk, and W.J. Nicklas Chemically induced hypoglycemia and anoxia: relationship to glutamate receptor-mediated toxicity in retina J. Pharmacol. Exp. Ther. 253 1990 1285 1292
92. G.D. Zeevalk, A.G. Hyndman, and W.J. Nicklas Excitatory amino acid-induced toxicity in chick retina: amino acid release, histology, and effects of chloride channel blockers J. Neurochem. 53 1989 1610 1619
93. X. Zhang, and S.K. Chintala Influence of interleukin-1 beta induction and mitogen-activated protein kinase phosphorylation on optic nerve ligation-induced matrix metalloproteinase-9 activation in the retina Exp. Eye Res. 78 2004 849 860
94. X. Zhang, T. Sakamoto, Y. Hata, T. Kubota, T. Hisatomi, T. Murata, T. Ishibashi, and H. Inomata Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats Exp. Eye Res. 74 2002 577 584
95. X. Zhang, A. Chaudhry, and S.K. Chintala Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage Mol. Vis. 9 2003 238 248
96. X. Zhang, M. Cheng, and S.K. Chintala Kainic acid-mediated upregulation of matrix metalloproteinase-9 promotes retinal degeneration Invest. Ophthalmol. Vis. Sci. 45 2004 2374 2383